Latest Continuous Disclosure News

Gateway Mining attributes recent share price gains to a newly published independent research report, while confirming ongoing assay results from its Yandal Project remain under review and will be disclosed progressively starting 22 April 2026.

Tusker Minerals Ltd has seen its TSKO securities suspended from ASX quotation immediately due to non-compliance with listing rules. The suspension applies solely to this security class while the company works to meet regulatory requirements.

Monash IVF has turned down a revised $0.90 per share acquisition proposal from a consortium led by Genesis Capital and WHSP Holdings, citing significant undervaluation and confidence in its new CEO’s growth strategy.

Highfield Resources (ASX:HFR) has dismissed any undisclosed material information as the cause of its recent share price jump, attributing the volatility to global geopolitical tensions impacting fertiliser raw materials.

Atomo Diagnostics has responded to ASX queries confirming it first held market-sensitive information after Lumos Diagnostics’ FDA CLIA waiver approval for FebriDx. The company defended its trading halt and capital raise timing, asserting full compliance with ASX Listing Rules.

Emu NL's EMUOA securities have been suspended from trading by the ASX, pending compliance with listing rules. This move affects only the EMUOA class and signals regulatory scrutiny ahead of the company's next steps.

ION Video Ltd has responded to ASX inquiries by confirming its recent discussions with Meta Platforms and Alphabet remain preliminary, with no binding agreements or commercial terms agreed. The company emphasised that the engagements are exploratory and non-binding, explaining why earlier disclosure was not required.

Macarthur Minerals (ASX:MIO) has clarified the timing of its cleansing notice relative to a key Programme of Work approval, affirming compliance with ASX continuous disclosure rules and explaining the rationale behind delayed disclosure.

Burgundy Diamond Mines has responded to ASX scrutiny over its related-party financing with Choron Holdings, asserting the arrangements were short-term, non-material cash-flow facilities properly disclosed in its half-year accounts.

Rhythm Biosciences has clarified inconsistencies in its disclosures around termination events in its underwriting agreement for RHYO options, following an ASX query. The company acknowledged an incomplete initial summary and administrative oversights but confirmed the agreement remains in full effect.

Tarrina Resources (ASX: TR8) has addressed ASX’s query on recent share price movement, confirming it has dispatched soil and drill core samples for laboratory testing with results expected by late April. The company maintains strict confidentiality protocols and affirms compliance with continuous disclosure rules.

ION Video has entered substantive early-stage discussions with Meta and Alphabet, exploring potential applications of its patented video virtualization technology. These talks are part of a broader engagement with major global tech players, though no formal deals have yet been struck.